Benzinga | Oct 28, 2021 07:48AM EDT

Abiomed Q2 EPS $1.03 Beats $0.97 Estimate, Sales $248.10M Beat $247.66M Estimate

Abiomed (NASDAQ:ABMD) reported quarterly earnings of $1.03 per share which beat the analyst consensus estimate of $0.97 by 6.19 percent. This is a 1.98 percent increase over earnings of $1.01 per share from the same period last year. The company reported quarterly sales of $248.10 million which beat the analyst consensus estimate of $247.66 million by 0.18 percent. This is a 18.28 percent increase over sales of $209.76 million the same period last year.